Advanz Pharma Specialty Medicine Switzerland GmbH - Mynzepli 40 mg/ml, Injektionslösung Swissmedic Registration 70618 Sequence 01 Product name Mynzepli 40 mg/ml Description Injektionslösung ATC-Classification S01LA05 ATC-Description Aflibercept Introduction of Sequence 13.05.2026
Composition afliberceptum 2 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, poloxamerum 188, aqua ad iniectabile q.s. ad solutionem pro 0.05 ml. Packungsbestandteile Galenic Form Injection solution Excipiens Active Agent Dose Afliberceptum 2mg / 0.05ml
BAG: Active Agent Afliberceptum
Inactive agents Dose Histidin Hydrochloride Monohydrate Histidine Poloxamer 188 Trehalosum Dihydricum
Package number Package Size EFP CP Category SL Out of trade (MedRef) 001 417.33 478.45 B SL No
